Suzuki Y
J Toxicol Environ Health. 1980 May;6(3):469-82. doi: 10.1080/15287398009529866.
Male Sprague-Dawley rats were given sc injections of Cd at 0.5 mg/kg body weight, 6 d/wk, for 22 wk. Concentrations in the liver, kidney, spleen, heart, testis, and blood were determined every week for 8 wk and at the end of 10, 12, 15, and 22 wk. Daily excretion of Cd and total protein in urine were determined every week in another series of rats given the same dose for up to 25 wk. Hepatic and renal Cd increased linearly for the first several weeks of Cd injection. The Cd concentration in the kidney leveled off at 156 microgram/g wet tissue after 7 wk, whereas hepatic Cd continued to increase for a few more weeks, reached its maximum level (330 microgram/g) at 10 wk, and then declined. Blood Cd showed a steady increase expressed by a logarithmic curve for the first several weeks and a rapid rise in response to the decline of hepatic Cd. Urinary excretion of Cd increased linearly but slightly for several weeks from the beginning of injections. In this period daily excretion of Cd remained less than 1% of the daily Cd dose. From 6 wk the Cd excretion increased rapidly and reached a plateau of about 10 microgram/d (several percent of the daily dose) with a simultaneous increase in urinary excretion of total protein. Urinary excretion of Cd showed a second sharp increase after 10 wk and reached a higher plateau level of 95 microgram/d (about 63% of the daily dose). From these findings the response of the exposed animals could be divided into three stages. The first stage was characterized by a steady increase in hepatic and renal Cd and low-level excretion in the urine. This stage was regarded as a latent period of Cd poisoning. The second stage, which developed between 5 and 7 wk, was characterized by leveling off of Cd accumulation in the kidney and increased excretion of Cd and total protein in the urine. This was an initial toxic stage represented by renal lesions. The third stage was characterized by the second sharp increase in urinary Cd excretion and an elevated level of blood Cd after 10 wk. These responses were related to a decrease in the hepatic capacity for Cd retention as a result of toxic effects of Cd on the liver.
将体重0.5毫克/千克的氯化镉皮下注射给雄性Sprague-Dawley大鼠,每周6天,共22周。在8周内每周测定一次肝脏、肾脏、脾脏、心脏、睾丸和血液中的浓度,并在第10、12、15和22周结束时进行测定。在另一组接受相同剂量长达25周的大鼠中,每周测定一次尿液中镉和总蛋白的每日排泄量。在注射镉的最初几周,肝脏和肾脏中的镉呈线性增加。7周后,肾脏中的镉浓度稳定在156微克/克湿组织,而肝脏中的镉继续增加几周,在第10周达到最高水平(330微克/克),然后下降。血液中的镉在最初几周呈对数曲线稳定增加,随着肝脏中镉的下降而迅速上升。从注射开始的几周内,尿液中镉的排泄呈线性但略有增加。在此期间,镉的每日排泄量仍低于每日镉剂量的1%。从第6周开始,镉的排泄迅速增加,达到约10微克/天的平台期(约为每日剂量的百分之几),同时尿液中总蛋白的排泄量也增加。尿液中镉的排泄在第10周后出现第二次急剧增加,达到95微克/天的更高平台期水平(约为每日剂量的63%)。根据这些发现,暴露动物的反应可分为三个阶段。第一阶段的特征是肝脏和肾脏中的镉稳定增加,尿液排泄水平较低。这个阶段被认为是镉中毒的潜伏期。第二阶段在第5至7周之间出现,其特征是肾脏中镉的积累趋于平稳,尿液中镉和总蛋白的排泄增加。这是一个以肾脏病变为代表的初始中毒阶段。第三阶段的特征是尿液中镉排泄量在第10周后第二次急剧增加,血液中镉水平升高。这些反应与镉对肝脏的毒性作用导致肝脏保留镉的能力下降有关。